Latest Breaking News On - Therapeutics announces - Page 3 : comparemela.com

Treadwell Therapeutics Announces a Presentation at the 2023 ASH Annual Meeting and Advisory Board Meeting

Treadwell Therapeutics Announces a Presentation at the 2023 ASH Annual Meeting and Advisory Board Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Texas
Toronto
Ontario
Canada
American
Roger-sidhu
Gautam-borthakur
Department-of-leukemia
American-society-of-hematology
Advisory-board-co
Division-of-cancer-medicine

Seelos Therapeutics Announces 1-for-30 Reverse Stock Split

Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its Board of Directors approved a.

New-york
United-states
Mike-moyer
Anthony-marciano
Lifesci-advisors
Seelos-therapeutics-inc
Prnewswire-seelos-therapeutics-inc
Nasdaq
Therapeutics-announces
Nasdaq-capital-market
Nasdaq-capital
Seelos-therapeutics

Flashpoint Therapeutics Announces $10M Seed Financing Led by Beta Lab to Pioneer Nanotechnology-Enabled Medicines

Flashpoint Therapeutics Announces $10M Seed Financing Led by Beta Lab to Pioneer Nanotechnology-Enabled Medicines
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Saudi-arabia
Riyadh
Ar-riya
Adam-margolin
Russell-carson
Chad-mirkin
Anderson-stowe
Quinten-stevens
Abdulrahman-al-olayen
Beta-lab-to-pioneer-nanotechnology
Russell-carson-cs-venture-opportunities-fund
International-institute-for-nanotechnology-at-northwestern-university

Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone 10-Oct-2023 / 07:00 CET/CEST Release of an ad hoc a.

Monza
Lombardia
Italy
Secheron
Switzerland-general
Switzerland
Balerna
Germany
Geneva
Genè
Swiss
Jeremy-meinen

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Balerna
Switzerland-general
Switzerland
Geneva
Genè
Germany
Italy
Secheron
Monza
Lombardia
Swiss
Jeremy-meinen